2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$11.60+$0.15 (+1.32%)
Price as of Aug 03, 2026 7:03 AM EDT- $1.0BMarket Cap
- 114.82%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$11.60+$0.15 (+1.32%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.45 | ||
Change | -$0.37 (-3.13%) | ||
Open | $11.77 | ||
High | $11.87 | ||
Low | $11.37 | ||
Previous Close | $11.82 | ||
Volume | 709,778 | ||
30-Day Average Volume | 1,097,910 | ||
1-Week Change | -2.14% | ||
1-Month Change | -8.47% | ||
1-Year Change | 114.82% | ||
3-Year Change | 32.37% | ||
5-Year Change | -51.24% | ||
Fundamentals | |||
Shares Outstanding | 87.3M | ||
Total Assets | $530.6M | ||
Market Cap | $1.0B | ||
Enterprise Value | $950.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.1M | ||
Free Cash Flow | -$46.0M | ||
EBIT | -$53.0M | ||
EBITDA | -$52.9M | ||
Net Working Capital | $466.1M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -22 | ||
PEG | 7 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue